TITLE:
      Infusion Laboratory: Protocol 5 (Flupenthixol) - 14
SUMMARY:
      The purpose of this study is to evaluate clinical safety issues pertaining to flupenthixol,
      to cocaine, and to their interaction, and to determine how pretreatment with flupenthixol
      modifies the subjective as well as physiological effects of cocaine. Taken together, these
      relatively D-1 selective agents can help determine the extent to which DA-1 binding affects
      the reinforcing effects of stimulants.
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

        M/F, ages 21-50. Meet DSM-IV criteria for cocaine dependence. Agree to conditions of the
        study and sign informed consent.

        Exclusion Criteria:

        Psychiatric disorder that requires medication therapy. History of seizures. Pregnant
        and/or nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics.
        Acute hepatitis. Other medical condtions that deem participation to be unsafe.
